Progress on share buyback programme

Progress on share buyback programme GlobeNewswire October 21, 2025 Progress on share buyback programme ING announced today that, as part of our EUR2.0 billion share buyback programme announced on 2 May 2025, in total 4,381,000 shares were repurchased during the week of 13 October 2025 up to and including 17 October 2025. The shares were […]

PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)

PIVOT-PO Phase 3 Data Show Tebipenem HBr's Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs) GlobeNewswire October 21, 2025 Data presented at IDWeek 2025 after study stopped early for efficacy Primary endpoint met, demonstrating non-inferiority of oral tebipenem HBr compared to intravenous treatment1 Data will be shared with

Caledonia Mining Corporation Plc Third Quarter Production at Blanket Mine

Caledonia Mining Corporation Plc Third Quarter Production at Blanket Mine Production tracking increased guidance at Blanket Mine GlobeNewswire October 21, 2025 ST HELIER, Jersey, Oct. 21, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (NYSE AMERICAN, AIM and VFEX: CMCL) (“Caledonia” or “the Company”) announces gold production from the Blanket Mine in Zimbabwe (“Blanket”) for

Art Along the Silk Road in Shaanxi

This is a news release from theShaanxi Provincial Department of Culture and Tourism: On the evening of October 16, 2025, the curtain rose on the 11th Silk Road International Arts Festival at the Xi'an Performing Art Center. As the historic starting point of the ancient Silk Road, Xi'an once again became a vibrant cultural crossroads,

Levi & Korsinsky Notifies WPP plc (WPP) Shareholders of Class Action Lawsuit and December 8, 2025 Deadline

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=173167&wire=1&utm_campaign=15

Investors in V.F. Corporation (VFC): Protect Your Rights – Contact Levi & Korsinsky Before November 12, 2025

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=173166&wire=1&utm_campaign=11

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. So what: If you purchased aTyr Pharma common stockduring the

Headwolf Titan 1 — 8.8″ Gaming Tablet Built for Power

In the fast-paced world of mobile gaming, U.S. consumers crave a tablet that blends uncompromising performance with the portability to game anytime, anywhere.Headwolf answers this call with the launch of the Titan 1- a flagship gaming tablet engineered to deliver console-level power in a sleek, one-hand-friendly design, making it the perfect companion for commutes, casual

Embla Medical hf: Interim Report Q3 2025

Announcement no. 49/2025 Interim report Q3 2025 21 October 2025 Sveinn Sölvason, President and CEO, comments: “Sales in Q3 2025 amounted to USD 237 million, representing 11% reported growth, of which 7% was organic. Growth picked up in the third quarter as expected, driven by double-digit growth in Prosthetics & Neuro Orthotics. The solid momentum

Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation

(Brussels:GLPG),(Euronext Amsterdam:GLPG), Intention follows comprehensive strategic review process and would represent the optimal capital allocation pathway to support a stronger and sustainable future for Galapagos Mechelen, Belgium; October 21, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced its intention to wind down its cell therapy business

Scroll to Top